Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives

Archives of Gynecology and Obstetrics
Nikolaos VrachnisGeorge Creatsas

Abstract

Diabetes mellitus, the prevalence of which has increased dramatically worldwide, may put patients at a higher risk of cancer. The aim of our study is the clarification of the possible mechanisms linking diabetes mellitus and gynecological cancer and their epidemiological relationship. This is a narrative review of the current literature, following a search on MEDLINE and the Cochrane Library, from their inception until January 2012. Articles investigating gynecologic cancer (endometrial, ovarian, and breast) incidence in diabetic patients were extracted. The strong evidence for a positive association between diabetes mellitus and the risk for cancer indicates that energy intake in excess to energy expenditure, or the sequelae thereof, is involved in gynecological carcinogenesis. This risk may be further heightened by glucose which can directly promote the production of tumor cells by functioning as a source of energy. Insulin resistance accompanied by secondary hyperinsulinemia is hypothezised to have a mitogenic effect. Steroid hormones are in addition potent regulators of the balance between cellular differentiation, proliferation, and apoptosis. Inflammatory pathways may also be implicated, as a correlation seems to exist be...Continue Reading

References

Nov 1, 1996·Cancer Causes & Control : CCC·R Kaaks
Jan 1, 1997·British Journal of Cancer·R TalaminiC La Vecchia
Oct 6, 1997·Journal of the National Cancer Institute·L WideroffJ H Olsen
Dec 9, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F ParazziniG Bolis
Mar 5, 1999·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·E M Rutanen
Sep 11, 1999·Cancer Causes & Control : CCC·I PerssonC Schairer
Dec 22, 1999·International Journal of Epidemiology·H A WeissJ B Schoenberg
Feb 17, 2000·Journal of the National Cancer Institute·R K RossM C Pike
Mar 24, 2000·Endocrine-related Cancer·T J Key
May 18, 2000·JAMA : the Journal of the American Medical Association·S M GapsturA Dyer
Jun 17, 2000·Endocrine Reviews·H M KhandwalaK E Friend
Sep 21, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J E Nestler
Nov 7, 2000·Cancer Causes & Control : CCC·E Salazar-MartínezM Hernández-Avila
Mar 7, 2001·Lancet·F Balkwill, A Mantovani
Apr 20, 2001·The Proceedings of the Nutrition Society·R Kaaks, A Lukanova
Mar 19, 2002·The Journal of Steroid Biochemistry and Molecular Biology·Dezhong J Liao, Robert B Dickson
Aug 16, 2002·American Journal of Epidemiology·Pamela J MinkAaron R Folsom
Nov 8, 2002·Cancer Causes & Control : CCC·Elisabete WeiderpassHans-Olov Adami
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Dec 4, 2003·International Journal of Cancer. Journal International Du Cancer·Annekatrin LukanovaAnne Zeleniuch-Jacquotte
Feb 21, 2004·CA: a Cancer Journal for Clinicians·Ahmedin JemalUNKNOWN American Cancer Society
Mar 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Luigino Dal MasoCarlo La Vecchia
Jun 12, 2004·American Journal of Epidemiology·Steven S CoughlinMichael J Thun
Aug 24, 2004·Journal of Cancer Research and Clinical Oncology·L M BersteinJ H H Thijssen
Jan 13, 2005·JAMA : the Journal of the American Medical Association·Sun Ha JeeJonathan M Samet
Feb 3, 2005·The Lancet Oncology·Ido WolfBella Kaufman
May 5, 2005·American Journal of Epidemiology·Wang Hong XuXiao Ou Shu
Dec 14, 2005·Molecular and Cellular Biochemistry·David C SeldinIsabel Dominguez
Mar 1, 2007·Diabetes Care·Pär StattinRudolf Kaaks
Apr 3, 2007·International Journal of Cancer. Journal International Du Cancer·Susanna C LarssonAlicja Wolk
Apr 12, 2007·The Journal of Clinical Endocrinology and Metabolism·Anthony J G HanleySteven M Haffner
Feb 13, 2008·The American Journal of Clinical Nutrition·Fei Xue, Karin B Michels
May 14, 2008·Current Pharmaceutical Design·Riichiro Abe, Sho-ichi Yamagishi
May 23, 2008·Gynecologic Oncology·Walter H GotliebIlan Bruchim
Jul 22, 2008·Advances in Experimental Medicine and Biology·Anette HjartåkerElisabete Weiderpass
Apr 23, 2009·Molecular Oncology·Peter A FaschingUNKNOWN OCAC (Ovarian Cancer Association Consortium)
May 30, 2009·Journal of Leukocyte Biology·Ravichandran RamasamyAnn Marie Schmidt
Jun 3, 2009·Archives of Physiology and Biochemistry·Susen BeckerRudolf Kaaks
Jul 10, 2009·International Journal of Cancer. Journal International Du Cancer·Geoffrey C KabatThomas E Rohan

❮ Previous
Next ❯

Citations

Sep 21, 2016·International Journal of Endocrinology·Hadar GoldvaserRinat Yerushalmi
Oct 19, 2016·Gynecologic Oncology·Eric R CraigRebecca C Arend
Feb 11, 2018·Clinical Chemistry and Laboratory Medicine : CCLM·Emanuela AnastasiSusanna Morano
Oct 28, 2017·The Cochrane Database of Systematic Reviews·Naomi S ClementWilliam Atiomo
Aug 28, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Xiaochen ZhangAshley S Felix
May 17, 2017·Archives of Gynecology and Obstetrics·Tamar TzurAdi Y Weintraub
Dec 14, 2018·BMC Cancer·Setareh AkhavanElahe Rezayof
Dec 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michaela A OnstadKaren H Lu
Mar 5, 2020·Revista da Associação Médica Brasileira·Millena Prata JammalRosekeila Simões Nomelini
Nov 6, 2020·Cancer·Michael S SimonJennifer L Beebe-Dimmer
Dec 30, 2020·Cancers·Ludwig KieselMichael Eichbaum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i
Camelia Cristina CojocaruGh Costăchescu
Gynecologic Oncology
Nicole S NevadunskyMark H Einstein
© 2021 Meta ULC. All rights reserved